[High prices and low clinical benefit: anomalies of the drug market]

Epidemiol Prev. 2018 Jan-Feb;42(1):92-93. doi: 10.19191/EP18.1.P092.025.
[Article in Italian]
No abstract available

MeSH terms

  • Commerce
  • Cost-Benefit Analysis
  • Drug Costs
  • Editorial Policies
  • Humans
  • Periodicals as Topic
  • Pharmaceutical Preparations / economics*
  • Public Health / economics
  • Technology Assessment, Biomedical
  • Treatment Outcome

Substances

  • Pharmaceutical Preparations